Assunta Lombardi - Concepedia

Author

Assunta Lombardi

University of Naples Federico II ORCID

Also Known As

A J Lombardi, A LOMBARDI, A Lombardi, A. LOMBARDI, A. Lombardi, Assonta LOMBARDI, Assunta Lombardi, Lombardi, A.

186

Publications

6.5K

Citations

H-Index

124

Concepts

All Affiliations

University of Naples Federico II University of Sannio University of Campania "Luigi Vanvitelli"University of Urbino Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Assunta Lombardi is an author at University of Naples Federico II specializing in medicine, physiology, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	50	2.7K
2	Health Sciences	19	28	1.3K
3	Natural Sciences	4	4	183
4	Public Health	1	1	81
5	Social Sciences	1	1	176

Assunta Lombardi

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study Leanne M. Ward, Frank Rauch, Michael P. Whyte, The Journal of Clinical Endocrinology & Metabolism	2010	218
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. Ethel S. Siris, Robert S. Weinstein, Roy D. Altman, The Journal of Clinical Endocrinology & Metabolism Bone DiseaseUrologyBone HealthAlendronate Versus EtidronateChronic Kidney Disease	1996	210
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis J. P. Devogelaer, H Bröll, R Correa-Rotter, Bone Bone DiseaseOrthopaedic SurgeryOral Alendronate InducesBone MassMenopause	1996	190
Brain Uncoupling Protein 2: Uncoupled Neuronal Mitochondria Predict Thermal Synapses in Homeostatic Centers Tamás Horváth, Craig H. Warden, Mihály Hajós, Journal of Neuroscience Synaptic TransmissionMolecular BiologyNeurotransmissionCellular PhysiologySocial Sciences	1999	176
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis S. Adámi, M Passeri, S. Ortolani, Bone Bone HealthMedicinePhysiologyBone MassBone Turnover	1995	142
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial Henry G. Bone, DW Dempster, John A. Eisman, Osteoporosis International	2014	137
3,5‐Diiodo‐ <scp>L</scp> ‐thyronine powerfully reduces adiposity in rats by increasing the burning of fats Antonia Lanni, María Moreno, Assunta Lombardi, The FASEB Journal	2005	134
How the thyroid controls metabolism in the rat: different roles for triiodothyronine and diiodothyronines María Moreno, Antonia Lanni, Assunta Lombardi, The Journal of Physiology	1997	128
Uncoupling Protein-3 Is a Molecular Determinant for the Regulation of Resting Metabolic Rate by Thyroid Hormone Pieter de Lange, Antonia Lanni, L. Beneduce, Endocrinology	2001	122
Expression of uncoupling protein‐3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle Antonia Lanni, L. Beneduce, Assunta Lombardi, FEBS Letters	1999	115

Page 1